Similar Search Results

Pharmaceutical pricing and reimbursement policies in Germany

Paris, Valérie (contributor); … - 2008

Persistent link: https://www.econbiz.de/10003793962

Value in pharmaceutical pricing

Paris, Valérie; Belloni, Annalisa - 2013

and price. …

Persistent link: https://www.econbiz.de/10009767907

Stockpiling at the onset of the COVID-19 pandemic : an empirical analysis of national prescription drug sales and prices

Park, Minje; Carson, Anita L.; Fox, Erin R.; Conti, Rena M. - In: Management science : journal of the Institute for … 70 (2024) 10, pp. 6483-6501

Persistent link: https://www.econbiz.de/10015138180

In whom we trust : the role of certification agencies in online drug markets

Bate, Roger; Jin, Ginger Zhe; Mathur, Aparna - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 111-150

Persistent link: https://www.econbiz.de/10010345596

Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany : a statistical model

Heiden, Iris an der; Schiffhorst, Guido; Müller, Laura; … - In: Health economics review 14 (2024) 1, pp. 1-13

criteria are relevant for the negotiated price for new patented drugs in Germany. European reference prices (ERPs) are one … models are used to estimate margins instead of cross-price averages published in the literature. Methods Qualitative … squared errors in a linear mixed model in comparison to literature-based estimations with country-specific cross-price …

Persistent link: https://www.econbiz.de/10015358230

Which factor reduces pharmaceutical expenditure, number of entrants or price variance? : updated generic drug markets in South Korea

Son, Kyung-Bok - In: Health economics review 14 (2024) 1, pp. 1-10

markets in terms of effective competition, and to examine the effects of number of manufacturers and price variance on … maximum-minimum price variance (MMPV) and the maximum-weighted price variance (MWPV). Panel regression with fixed and time … differentiate generic prices, was associated with a decrease in the number of manufacturers and an increase in price dispersion. The …

Persistent link: https://www.econbiz.de/10015358438

Value-based pricing for drugs with uncertain clinical benefits

Jiao, Boshen; Hsieh, Yuli Lily; Li, Meng; Verguet, Stéphane - In: Health economics 34 (2025) 4, pp. 780-790

Persistent link: https://www.econbiz.de/10015358579

The health costs of cost sharing

Chandra, Amitabh; Flack, Evan; Obermeyer, Ziad - In: The quarterly journal of economics 139 (2024) 4, pp. 2037-2082

Persistent link: https://www.econbiz.de/10015358986

Regulation of mark-up on medicine prices in Zimbabwe : a pilot survey from 92 community pharmacies in the metropolitan area of Harare

Nakambale, Hilma N.; Tambama, Penelope; Bangalee, Varsha - In: Health economics review 14 (2024) 1, pp. 1-7

medicines had a median mark-up price of 62% while non-essential medicines had a mark-up of 56%. Antipsychotics had the highest …

Persistent link: https://www.econbiz.de/10015371744

Going through the roof : on prices for drugs sold through insurance

Kamphorst, Jurjen; Karamychev, Vladimir A. - In: Games and economic behavior 151 (2025), pp. 218-242

Persistent link: https://www.econbiz.de/10015426723